| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_938a6d7a15cbc93a74abe1953eb25d47 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C209-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-30 |
| filingDate |
2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8335026064ecb6dfc76d17914c3788b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_187d7d6f9a6b0bf26adfc8e279bf602c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eabb19ddae524321b3e75f137193a6ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e75910fdbb0914ddae5e29fef84622fd |
| publicationDate |
2022-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022036060-A1 |
| titleOfInvention |
Crystalline forms of cftr modulators |
| abstract |
Crystalline forms of salts of Compound I are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11591350-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11584761-B2 |
| priorityDate |
2020-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |